Watchlist Price Alert

Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · Real-Time Price · USD

7.83

-0.01 (-0.13%)

At close: May 15, 2025, 9:58 AM

Regulus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	38.53M	23.77M	24.23M	60.38M	31.09M	34.12M	13.94M	13.52M	76.11M
Short-Term Investments	37.25M	n/a	14.93M	n/a	n/a	n/a	n/a	46.55M	61.17M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	291K	277K	487K	326K	590K	342K
Receivables	n/a	n/a	n/a	n/a	503K	1.14M	26K	373K	1.66M
Inventory	n/a	3.01M	3.01K	3.01K	3.31M	3.92M	4.19M	4.78M	5.55M
Other Current Assets	3.08M	62K	62K	62K	n/a	1.22M	1.14M	1.51M	n/a
Total Current Assets	82.34M	28.18M	44.08M	65.23M	36.73M	40.41M	19.3M	66.74M	87.47M
Property-Plant & Equipment	1.81M	2.54M	2.58M	2.85M	472K	921K	7.81M	9.71M	11.83M
Goodwill & Intangibles	25K	33K	62K	83K	125K	266K	500K	775K	1.01M
Total Long-Term Assets	1.84M	2.57M	2.64M	3.22M	874K	1.67M	8.63M	11.07M	13.19M
Total Assets	84.18M	30.75M	46.72M	68.45M	37.6M	42.08M	27.93M	77.81M	100.66M
Account Payables	947K	204K	175K	285K	535K	1.32M	1.71M	5.74M	5.84M
Deferred Revenue	n/a	n/a	n/a	-589K	3.42M	6K	2.57M	72K	72K
Short-Term Debt	n/a	1.33M	4.51M	n/a	4.65M	14.63M	16.57M	19.86M	n/a
Other Current Liabilities	5.04M	5.36M	2.55M	1.29M	4.65M	4.72M	4.18M	4.94M	5.58M
Total Current Liabilities	7.5M	8.51M	11.66M	5.23M	11.58M	21.6M	26.65M	32.6M	13.73M
Long-Term Debt	n/a	n/a	n/a	4.67M	n/a	n/a	n/a	n/a	19.8M
Other Long-Term Liabilities	n/a	n/a	n/a	1.18M	n/a	468K	7.13M	8.07M	10.98M
Total Long-Term Liabilities	274K	1.05M	1.77M	8.27M	n/a	468K	7.13M	9.99M	30.85M
Total Liabilities	7.77M	9.56M	13.43M	13.5M	11.58M	22.07M	33.78M	42.59M	44.59M
Total Debt	274K	2.39M	6.28M	7.09M	4.65M	14.63M	16.57M	19.86M	19.8M
Common Stock	66K	20K	17K	146K	67K	21K	9K	104K	53K
Retained Earnings	-559.57M	-513.21M	-483.18M	-454.85M	-427.05M	-411.31M	-392.72M	-345.86M	-273.35M
Comprehensive Income	50K	n/a	-12K	n/a	n/a	n/a	-9.89M	-134K	-123K
Shareholders Equity	76.41M	21.19M	33.29M	54.96M	26.03M	20.02M	-5.85M	35.22M	56.08M
Total Investments	37.25M	n/a	14.93M	n/a	n/a	n/a	n/a	46.55M	61.17M